Management of localized low-grade follicular lymphomas

Australasian Radiology

Volumn 45, Issue 3, 2001, Pages 326-334

  MacManus, Michael P ^a   Seymour, John F ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Chemotherapy; Follicular lymphoma; Radiotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; MORTALITY; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; SURVIVAL; WHOLE BODY RADIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, LOW-GRADE; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SURVIVAL ANALYSIS; WHOLE-BODY IRRADIATION;

EID: 0035434050     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1673.2001.00930.x     Document Type: Article

References (13)

1. National Cancer Institute-sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical use. Cancer 1982; 49: 2112-18.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification - from controversy to consensus: The R.E.A.L & WHO classification of lymphoid neoplasms. Ann. Oncol. 2000; 11 (Suppl. 1): 3-10.
3. Baris D, Zahm SH. Epidemiology of lymphomas. Curr. Opin. Oncol. 2000; 12: 383-94.
4. Ngan B, Chen-Levy Z, Weiss L et al. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N. Engl. J. Med. 1988; 218: 1638-44.
5. Zwicky CS, Maddocks AB, Andersen N et al. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood 1996; 88: 3314-22.
6. Pusey WA. Cases of sarcoma and of Hodgkin's disease treated by exposures to X-rays: A preliminary report. JAMA 1902; 38: 166-71.
7. Senn N. Therapeutical value of Rontgen ray in the treatment of pseudoleukemia. N. Y. Med. J. 1903; 77: 665-70.
8. Peters MV. Prophylactic treatment of adjacent areas in Hodgkin's disease. Cancer Res. 1966; 26: 1232-40.
9. Kaplan HS, Rosenberg SA. Extended field radical radiotherapy in advanced Hodgkin's disease: Short term results of 2 randomized clinical trials. Cancer Res. 1966; 26: 1268-76.
10. Carbone PP, Kaplan HS, Musshof K et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31: 1860-1.
11. Rosenberg SA, Dorfman RF, Kaplan HS. The value of sequential bone marrow biopsy, and laparotomy and splenectomy in 127 consecutive untreated patients with non Hodgkin's lymphoma. Br. J. Cancer 1966; 31: 221-7.
12. Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 1993; 328: 1002-6.
13. Hayhoe FG. Chemotherapy in the management of stage III/IV grade I non-Hodgkin's lymphoma (Report no. 17). Clin. Radiol. 1981; 32: 547-52.